These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3092613

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF, Morganroth J.
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ.
    Circulation; 1990 Mar; 81(3):1123-7. PubMed ID: 1689621
    [No Abstract] [Full Text] [Related]

  • 27. Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the CAST study.
    Bayés de Luna A, Guindo J, Borja J, Roman M, Madoery C.
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):651-5. PubMed ID: 2127537
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Encainide.
    Colucci RD.
    Conn Med; 1988 Aug; 52(8):482-4. PubMed ID: 3139357
    [No Abstract] [Full Text] [Related]

  • 31. Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function.
    Sami MH, Derbekyan VA, Lisbona R.
    Am J Cardiol; 1983 Sep 01; 52(5):507-11. PubMed ID: 6412535
    [Abstract] [Full Text] [Related]

  • 32. [New anti-arrhythmia drugs].
    Vidal Garate J, Romero-Ayala LC, Cárdenas Loaeza M.
    Arch Inst Cardiol Mex; 1983 Sep 01; 53(2):159-78. PubMed ID: 6411015
    [Abstract] [Full Text] [Related]

  • 33. Encainide and flecainide in children: separating the wheat from the chaff.
    Perry JC, Garson A.
    J Am Coll Cardiol; 1991 Aug 01; 18(2):366-7. PubMed ID: 1906903
    [No Abstract] [Full Text] [Related]

  • 34. Fact and fiction--results of the cardiac arrhythmia suppression trial.
    Wyse DG.
    Can J Cardiol; 1991 Aug 01; 7(1):51-4; discussion 55-8. PubMed ID: 1902755
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Electrophysiology and pharmacology of aprindine, encainide, and propafenone.
    Zipes DP, Prystowsky EN, Heger JJ.
    Ann N Y Acad Sci; 1984 Aug 01; 432():201-9. PubMed ID: 6441495
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drug interaction studies and encainide use in renal and hepatic impairment.
    Quart BD, Gallo DG, Sami MH, Wood AJ.
    Am J Cardiol; 1986 Aug 29; 58(5):104C-113C. PubMed ID: 2875643
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. New antiarrhythmic agents: mexiletine, tocainide, encainide, flecainide, and amiodarone.
    Morganroth J.
    Ration Drug Ther; 1987 Apr 29; 21(4):1-6. PubMed ID: 3685373
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.